StonvexLoading…
StonvexStonvexStonvexCore line items from TUSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.03M | $44.29M | $46.80M | $32.00M |
Operating Income | $-869.00K | $-57.43M | $-45.93M | $-36.92M |
Net Income | $5.19M | $4.60M | $-4.30M | $8.31M |
EPS (Diluted) | $0.11 | $0.10 | $-0.09 | $0.18 |
Total Assets | $344.74M | $334.89M | $336.75M | $364.19M |
Total Liabilities | $81.79M | $76.61M | $87.51M | $102.16M |
Cash & Equivalents | $92.72M | $101.99M | $98.17M | $127.25M |
Free Cash Flow OCF − CapEx | $-14.74M | $-89.12M | $-53.71M | $-37.14M |
Shares Outstanding | 48.17M | 48.36M | 48.19M | 48.19M |